<VariationArchive VariationID="421795" VariationName="NM_001199107.2(TBC1D24):c.1360_1363dup (p.Pro455fs)" VariationType="Duplication" Accession="VCV000421795" Version="6" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-03-05" DateCreated="2017-04-27" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="409582" VariationID="421795">
      <GeneList>
        <Gene Symbol="TBC1D24" FullName="TBC1 domain family member 24" GeneID="57465" HGNC_ID="HGNC:29203" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="2475127" stop="2505730" display_start="2475127" display_stop="2505730" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="2525146" stop="2555733" display_start="2525146" display_stop="2555733" Strand="+" />
          </Location>
          <OMIM>613577</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001199107.2(TBC1D24):c.1360_1363dup (p.Pro455fs)</Name>
      <CanonicalSPDI>NC_000016.10:2500323:CAAGC:CAAGCAAGC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>16p13.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="2500323" stop="2500324" display_start="2500323" display_stop="2500324" variantLength="4" positionVCF="2500323" referenceAlleleVCF="C" alternateAlleleVCF="CCAAG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="2550324" stop="2550325" display_start="2550324" display_stop="2550325" variantLength="4" positionVCF="2550324" referenceAlleleVCF="C" alternateAlleleVCF="CCAAG" />
      </Location>
      <ProteinChange>P455fs</ProteinChange>
      <ProteinChange>P449fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.2500325_2500328dup" Assembly="GRCh38">
            <Expression>NC_000016.10:g.2500325_2500328dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.2550326_2550329dup" Assembly="GRCh37">
            <Expression>NC_000016.9:g.2550326_2550329dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_028170.1" sequenceAccession="NG_028170" sequenceVersion="1" change="g.30180_30183dup">
            <Expression>NG_028170.1:g.30180_30183dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001199107.2" sequenceAccession="NM_001199107" sequenceVersion="2" change="c.1360_1363dup" MANESelect="true">
            <Expression>NM_001199107.2:c.1360_1363dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001186036.1" sequenceAccession="NP_001186036" sequenceVersion="1" change="p.Pro455fs">
            <Expression>NP_001186036.1:p.Pro455fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_020705.3" sequenceAccession="NM_020705" sequenceVersion="3" change="c.1342_1345dup">
            <Expression>NM_020705.3:c.1342_1345dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_065756.1" sequenceAccession="NP_065756" sequenceVersion="1" change="p.Pro449fs">
            <Expression>NP_065756.1:p.Pro449fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA16620171" DB="ClinGen" />
        <XRef Type="rs" ID="1292551263" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001199107.2(TBC1D24):c.1360_1363dup (p.Pro455fs) AND not provided" Accession="RCV000485932" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2016-08-02" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001199107.2(TBC1D24):c.1360_1363dup (p.Pro455fs) AND multiple conditions" Accession="RCV002496869" Version="1">
        <ClassifiedConditionList TraitSetID="56342">
          <ClassifiedCondition DB="MedGen" ID="C3892048">Autosomal dominant nonsyndromic hearing loss 65</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C2829265">Autosomal recessive nonsyndromic hearing loss 86</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0795934">DOORS syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C3809173">Developmental and epileptic encephalopathy, 16</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0917800">Familial infantile myoclonic epilepsy</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1842531">Rolandic epilepsy-paroxysmal exercise-induced dystonia-writer's cramp syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-07-16" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001199107.2(TBC1D24):c.1360_1363dup (p.Pro455fs) AND multiple conditions" Accession="RCV002526609" Version="2">
        <ClassifiedConditionList TraitSetID="31132">
          <ClassifiedCondition DB="MedGen" ID="C3892048">Autosomal dominant nonsyndromic hearing loss 65</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="CN236805">Caused by mutation in the TBC1 domain family, member 24</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C3463992">Developmental and epileptic encephalopathy, 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-03-31" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-03-31" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2017-04-27" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">23526554</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24291220</ID>
        </Citation>
        <DescriptionHistory Dated="2023-02-02">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="31132" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1617" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">X-linked infantile spasms</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">West's syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tonic spasms with clustering, arrest of psychomotor development and hypsarrhythmia on EEG</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-Linked Infantile Spasm Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epileptic encephalopathy, early infantile, 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Developmental and epileptic encephalopathy, 1</ElementValue>
                <XRef ID="MONDO:0010632" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">OHTAHARA SYNDROME, X-LINKED</ElementValue>
                <XRef Type="MIM" ID="308350" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">INFANTILE SPASM SYNDROME, X-LINKED 1</ElementValue>
                <XRef Type="MIM" ID="308350" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">IS</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">DEE1</ElementValue>
                <XRef Type="MIM" ID="308350" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">ISSX1</ElementValue>
                <XRef Type="MIM" ID="308350" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000519156" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520979" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558371" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520051" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520996" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000551668" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000557944" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520995" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520998" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000332436" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520980" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529356" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592989" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">ARX-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15298" />
                <XRef ID="15298" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C3463992" DB="MedGen" />
              <XRef ID="MONDO:0010632" DB="MONDO" />
              <XRef Type="MIM" ID="308350" DB="OMIM" />
            </Trait>
            <Trait ID="35670" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Caused by mutation in the TBC1 domain family, member 24</ElementValue>
              </Name>
              <XRef ID="CN236805" DB="MedGen" />
            </Trait>
            <Trait ID="31927" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Autosomal dominant nonsyndromic hearing loss 65</ElementValue>
                <XRef ID="MONDO:0014470" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Deafness, autosomal dominant 65</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DFNA65</ElementValue>
                <XRef Type="MIM" ID="616044" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18140" />
                <XRef ID="18140" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">TBC1D24-related disorders comprise a continuum of features that were originally described as distinct, recognized phenotypes: DOORS syndrome (deafness, onychodystrophy, osteodystrophy, mental retardation, and seizures). Profound sensorineural hearing loss, onychodystrophy, osteodystrophy, intellectual disability / developmental delay, and seizures. Familial infantile myoclonic epilepsy (FIME). Early-onset myoclonic seizures, focal epilepsy, dysarthria, and mild-to-moderate intellectual disability. Progressive myoclonus epilepsy (PME). Action myoclonus, tonic-clonic seizures, progressive neurologic decline, and ataxia. Early-infantile epileptic encephalopathy 16 (EIEE16). Epileptiform EEG abnormalities which themselves are believed to contribute to progressive disturbance in cerebral function. Autosomal recessive nonsyndromic hearing loss, DFNB86. Profound prelingual deafness. Autosomal dominant nonsyndromic hearing loss, DFNA65. Slowly progressive deafness with onset in the third decade, initially affecting the high frequencies.</Attribute>
                <XRef ID="NBK274566" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">25719194</ID>
                <ID Source="BookShelf">NBK274566</ID>
              </Citation>
              <XRef ID="90635" DB="Orphanet" />
              <XRef ID="C3892048" DB="MedGen" />
              <XRef ID="MONDO:0014470" DB="MONDO" />
              <XRef Type="MIM" ID="616044" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="56342" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4931" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, IMPAIRED INTELLECTUAL DEVELOPMENT, AND SEIZURES SYNDROME</ElementValue>
                <XRef Type="MIM" ID="220500" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613577.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613577.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613577.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613577.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613577.0011" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Deafness onychodystrophy osteodystrophy and mental retardation syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Digitorenocerebral syndrome</ElementValue>
                <XRef ID="Digitorenocerebral+Syndrome/2280" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">DOORS syndrome</ElementValue>
                <XRef ID="320448" DB="GeneTests" />
                <XRef ID="MONDO:0009079" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">DRC SYNDROME</ElementValue>
                <XRef Type="MIM" ID="222760" DB="OMIM" />
                <XRef Type="MIM" ID="220500" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">BRACHYDACTYLY DUE TO ABSENCE OF DISTAL PHALANGES</ElementValue>
                <XRef Type="MIM" ID="222760" DB="OMIM" />
                <XRef Type="MIM" ID="220500" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ERONEN SYNDROME</ElementValue>
                <XRef Type="MIM" ID="220500" DB="OMIM" />
                <XRef Type="MIM" ID="222760" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DOORS</ElementValue>
                <XRef Type="MIM" ID="220500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">TBC1D24-related disorders comprise a continuum of features that were originally described as distinct, recognized phenotypes: DOORS syndrome (deafness, onychodystrophy, osteodystrophy, mental retardation, and seizures). Profound sensorineural hearing loss, onychodystrophy, osteodystrophy, intellectual disability / developmental delay, and seizures. Familial infantile myoclonic epilepsy (FIME). Early-onset myoclonic seizures, focal epilepsy, dysarthria, and mild-to-moderate intellectual disability. Progressive myoclonus epilepsy (PME). Action myoclonus, tonic-clonic seizures, progressive neurologic decline, and ataxia. Early-infantile epileptic encephalopathy 16 (EIEE16). Epileptiform EEG abnormalities which themselves are believed to contribute to progressive disturbance in cerebral function. Autosomal recessive nonsyndromic hearing loss, DFNB86. Profound prelingual deafness. Autosomal dominant nonsyndromic hearing loss, DFNA65. Slowly progressive deafness with onset in the third decade, initially affecting the high frequencies.</Attribute>
                <XRef ID="NBK274566" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000522937" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">TBC1D24-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1685" />
                <XRef ID="1685" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">25719194</ID>
                <ID Source="BookShelf">NBK274566</ID>
              </Citation>
              <XRef ID="3231" DB="Orphanet" />
              <XRef ID="79500" DB="Orphanet" />
              <XRef ID="C0795934" DB="MedGen" />
              <XRef ID="MONDO:0009079" DB="MONDO" />
              <XRef Type="MIM" ID="220500" DB="OMIM" />
            </Trait>
            <Trait ID="16955" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive nonsyndromic hearing loss 86</ElementValue>
                <XRef ID="MONDO:0013826" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Deafness, autosomal recessive 86</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DFNB86</ElementValue>
                <XRef Type="MIM" ID="614617" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="22643" />
                <XRef ID="22643" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">TBC1D24-related disorders comprise a continuum of features that were originally described as distinct, recognized phenotypes: DOORS syndrome (deafness, onychodystrophy, osteodystrophy, mental retardation, and seizures). Profound sensorineural hearing loss, onychodystrophy, osteodystrophy, intellectual disability / developmental delay, and seizures. Familial infantile myoclonic epilepsy (FIME). Early-onset myoclonic seizures, focal epilepsy, dysarthria, and mild-to-moderate intellectual disability. Progressive myoclonus epilepsy (PME). Action myoclonus, tonic-clonic seizures, progressive neurologic decline, and ataxia. Early-infantile epileptic encephalopathy 16 (EIEE16). Epileptiform EEG abnormalities which themselves are believed to contribute to progressive disturbance in cerebral function. Autosomal recessive nonsyndromic hearing loss, DFNB86. Profound prelingual deafness. Autosomal dominant nonsyndromic hearing loss, DFNA65. Slowly progressive deafness with onset in the third decade, initially affecting the high frequencies.</Attribute>
                <XRef ID="NBK274566" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">25719194</ID>
                <ID Source="BookShelf">NBK274566</ID>
              </Citation>
              <XRef ID="90636" DB="Orphanet" />
              <XRef ID="C2829265" DB="MedGen" />
              <XRef ID="MONDO:0013826" DB="MONDO" />
              <XRef Type="MIM" ID="614617" DB="OMIM" />
            </Trait>
            <Trait ID="1176" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Epilepsy, rolandic with paroxysmal exercise-induced dystonia and writer's cramp</ElementValue>
                <XRef ID="Epilepsy%2C+Rolandic+with+Paroxysmal+Exercise-Induced+Dystonia+and+Writer%27s+Cramp/2607" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Rolandic epilepsy-paroxysmal exercise-induced dystonia-writer's cramp syndrome</ElementValue>
                <XRef ID="MONDO:0011970" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">RE-PED-WC</ElementValue>
                <XRef Type="MIM" ID="608105" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">EPRPDC</ElementValue>
                <XRef Type="MIM" ID="608105" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17003" />
                <XRef ID="17003" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="163727" DB="Orphanet" />
              <XRef ID="C1842531" DB="MedGen" />
              <XRef ID="MONDO:0011970" DB="MONDO" />
              <XRef Type="MIM" ID="608105" DB="OMIM" />
            </Trait>
            <Trait ID="5585" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Familial infantile myoclonic epilepsy</ElementValue>
                <XRef ID="MONDO:0011506" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epilepsy, Myoclonic, Infantile</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">EIM</ElementValue>
                <XRef Type="MIM" ID="605021" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">FIME</ElementValue>
                <XRef Type="MIM" ID="605021" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">TBC1D24-related disorders comprise a continuum of features that were originally described as distinct, recognized phenotypes: DOORS syndrome (deafness, onychodystrophy, osteodystrophy, mental retardation, and seizures). Profound sensorineural hearing loss, onychodystrophy, osteodystrophy, intellectual disability / developmental delay, and seizures. Familial infantile myoclonic epilepsy (FIME). Early-onset myoclonic seizures, focal epilepsy, dysarthria, and mild-to-moderate intellectual disability. Progressive myoclonus epilepsy (PME). Action myoclonus, tonic-clonic seizures, progressive neurologic decline, and ataxia. Early-infantile epileptic encephalopathy 16 (EIEE16). Epileptiform EEG abnormalities which themselves are believed to contribute to progressive disturbance in cerebral function. Autosomal recessive nonsyndromic hearing loss, DFNB86. Profound prelingual deafness. Autosomal dominant nonsyndromic hearing loss, DFNA65. Slowly progressive deafness with onset in the third decade, initially affecting the high frequencies.</Attribute>
                <XRef ID="NBK274566" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">TBC1D24-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17521" />
                <XRef ID="17521" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">25719194</ID>
                <ID Source="BookShelf">NBK274566</ID>
              </Citation>
              <XRef ID="352582" DB="Orphanet" />
              <XRef ID="C0917800" DB="MedGen" />
              <XRef ID="MONDO:0011506" DB="MONDO" />
              <XRef Type="MIM" ID="605021" DB="OMIM" />
            </Trait>
            <Trait ID="18003" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Developmental and epileptic encephalopathy, 16</ElementValue>
                <XRef ID="MONDO:0014133" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Early infantile epileptic encephalopathy 16</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DEE16</ElementValue>
                <XRef Type="MIM" ID="615338" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">TBC1D24-related disorders comprise a continuum of features that were originally described as distinct, recognized phenotypes: DOORS syndrome (deafness, onychodystrophy, osteodystrophy, mental retardation, and seizures). Profound sensorineural hearing loss, onychodystrophy, osteodystrophy, intellectual disability / developmental delay, and seizures. Familial infantile myoclonic epilepsy (FIME). Early-onset myoclonic seizures, focal epilepsy, dysarthria, and mild-to-moderate intellectual disability. Progressive myoclonus epilepsy (PME). Action myoclonus, tonic-clonic seizures, progressive neurologic decline, and ataxia. Early-infantile epileptic encephalopathy 16 (EIEE16). Epileptiform EEG abnormalities which themselves are believed to contribute to progressive disturbance in cerebral function. Autosomal recessive nonsyndromic hearing loss, DFNB86. Profound prelingual deafness. Autosomal dominant nonsyndromic hearing loss, DFNA65. Slowly progressive deafness with onset in the third decade, initially affecting the high frequencies.</Attribute>
                <XRef ID="NBK274566" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15945" />
                <XRef ID="15945" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">25719194</ID>
                <ID Source="BookShelf">NBK274566</ID>
              </Citation>
              <XRef ID="293181" DB="Orphanet" />
              <XRef ID="352596" DB="Orphanet" />
              <XRef ID="C3809173" DB="MedGen" />
              <XRef ID="MONDO:0014133" DB="MONDO" />
              <XRef Type="MIM" ID="615338" DB="OMIM" />
            </Trait>
            <Trait ID="31927" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Autosomal dominant nonsyndromic hearing loss 65</ElementValue>
                <XRef ID="MONDO:0014470" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Deafness, autosomal dominant 65</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DFNA65</ElementValue>
                <XRef Type="MIM" ID="616044" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18140" />
                <XRef ID="18140" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">TBC1D24-related disorders comprise a continuum of features that were originally described as distinct, recognized phenotypes: DOORS syndrome (deafness, onychodystrophy, osteodystrophy, mental retardation, and seizures). Profound sensorineural hearing loss, onychodystrophy, osteodystrophy, intellectual disability / developmental delay, and seizures. Familial infantile myoclonic epilepsy (FIME). Early-onset myoclonic seizures, focal epilepsy, dysarthria, and mild-to-moderate intellectual disability. Progressive myoclonus epilepsy (PME). Action myoclonus, tonic-clonic seizures, progressive neurologic decline, and ataxia. Early-infantile epileptic encephalopathy 16 (EIEE16). Epileptiform EEG abnormalities which themselves are believed to contribute to progressive disturbance in cerebral function. Autosomal recessive nonsyndromic hearing loss, DFNB86. Profound prelingual deafness. Autosomal dominant nonsyndromic hearing loss, DFNA65. Slowly progressive deafness with onset in the third decade, initially affecting the high frequencies.</Attribute>
                <XRef ID="NBK274566" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">25719194</ID>
                <ID Source="BookShelf">NBK274566</ID>
              </Citation>
              <XRef ID="90635" DB="Orphanet" />
              <XRef ID="C3892048" DB="MedGen" />
              <XRef ID="MONDO:0014470" DB="MONDO" />
              <XRef Type="MIM" ID="616044" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1106212" SubmissionDate="2019-01-29" DateLastUpdated="2017-04-27" DateCreated="2017-04-27">
        <ClinVarSubmissionID localKey="GDX:1134230|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000571105" DateUpdated="2017-04-27" DateCreated="2017-04-27" Type="SCV" Version="3" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-08-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>A novel c.1360_1363dupAAGC variant that is likely pathogenic has been identified in the TBC1D24 gene. The c.1360_1363dupAAGC variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. It was not observed in approximately 6,300 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The c.1360_1363dupAAGC variant in the TBC1D24 gene causes a frameshift starting with codon Proline 455, changes this amino acid to a Glutamine residue and creates a premature Stop codon at position 24 of the new reading frame, denoted p.Pro455GlnfsX24. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. Therefore, this variant is likely pathogenic; however, the possibility that it is benign cannot be excluded.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TBC1D24" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="16" alternateAllele="AAGCAAGC" referenceAllele="AAGC" start="2550329" stop="2550330" variantLength="2" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001199107.1:c.1360_1363dupAAGC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5458369" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_001199107.2:c.1360_1363dup|OMIM:220500;605021;608105;614617;615338;616044" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002805572" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-07-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001199107.2:c.1360_1363dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="220500" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="605021" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="608105" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614617" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="615338" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="616044" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6188854" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="804836|MedGen:C3809181;C3463992;CN220131" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003500032" DateUpdated="2024-02-28" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23526554</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24291220</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 421795). This variant has not been reported in the literature in individuals affected with TBC1D24-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.04%). This sequence change creates a premature translational stop signal (p.Pro455Glnfs*24) in the TBC1D24 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TBC1D24 are known to be pathogenic (PMID: 23526554, 24291220).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TBC1D24" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000016.9:g.2550324_2550325insCAAG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Finding">
            <XRef DB="MedGen" ID="C3809181" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3463992" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN220131" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5458369" TraitType="Disease" MappingType="XRef" MappingValue="605021" MappingRef="OMIM">
        <MedGen CUI="C0917800" Name="Familial infantile myoclonic epilepsy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6188854" TraitType="Disease" MappingType="XRef" MappingValue="C3463992" MappingRef="MedGen">
        <MedGen CUI="C3463992" Name="Developmental and epileptic encephalopathy, 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5458369" TraitType="Disease" MappingType="XRef" MappingValue="608105" MappingRef="OMIM">
        <MedGen CUI="C1842531" Name="Rolandic epilepsy-paroxysmal exercise-induced dystonia-writer's cramp syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6188854" TraitType="Finding" MappingType="XRef" MappingValue="C3809181" MappingRef="MedGen">
        <MedGen CUI="CN236805" Name="Caused by mutation in the TBC1 domain family, member 24" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1106212" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5458369" TraitType="Disease" MappingType="XRef" MappingValue="616044" MappingRef="OMIM">
        <MedGen CUI="C3892048" Name="Autosomal dominant nonsyndromic hearing loss 65" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5458369" TraitType="Disease" MappingType="XRef" MappingValue="614617" MappingRef="OMIM">
        <MedGen CUI="C2829265" Name="Autosomal recessive nonsyndromic hearing loss 86" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5458369" TraitType="Disease" MappingType="XRef" MappingValue="220500" MappingRef="OMIM">
        <MedGen CUI="C0795934" Name="DOORS syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5458369" TraitType="Disease" MappingType="XRef" MappingValue="615338" MappingRef="OMIM">
        <MedGen CUI="C3809173" Name="Developmental and epileptic encephalopathy, 16" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6188854" TraitType="Disease" MappingType="XRef" MappingValue="CN220131" MappingRef="MedGen">
        <MedGen CUI="C3892048" Name="Autosomal dominant nonsyndromic hearing loss 65" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

